Что произошло на ПМЭФ? К чему приведут выборы в Армении?

Want to profit from trends without worrying about lost profits? The managers at Moscow Partners will analyze market trends for you, decide which assets to enter and when to exit—and profitably. Sign up for a free consultation using the link below: https://moscowpartners.com/ru/contact... or call: +7 495 136-20-48 Advertising. Moscow Partners LLC. Taxpayer Identification Number (INN) 7729605134. erid: 2W5zFGfJPRK Securities trust management services are provided by Moscow Partners LLC (Bank of Russia license 045-13636-001000 dated June 30, 2011). You can learn more about the asset management terms, the manager, and other information on the Moscow Partners LLC website: https://moscowpartners.com, at the office at 23 Maly Tishinsky Lane, Bldg. 1, Moscow, 123056, or by phone: +7 (495) 787-52-56. This is not individual investment advice. Biotech: A strategy for investing in the innovative medicine sector. A selection of companies from the biotechnology, pharmaceuticals, and medical technology sectors with different growth drivers. High risk. Learn more and connect in the Bitkogan app. Download — https://clck.ru/3TzxgX?erid=2W5zFJnL2GH Advertisement. Advertiser: FINANCE.ANALYTICS.NEWS LLC. OGRN 1227700077373. erid: 2W5zFJnL2GH 00:00 - Introduction 00:48 - Moscow Partners 04:13 - About the Russian-Ukrainian track and Zelensky's letter to Putin 14:50 - Budget deficit and interest rate cuts 26:23 - SPIEF results 35:20 - New sanctions against Russia and the spirit of Anchorage 45:00 - New strategy in the Bitkogan app 46:58 - What's going on between the US, Iran, and Israel? 1:00:00 - Why did the market sag? 1:10:20 - New US tariffs on trading partners 1:17:00 - Annual inflation in Russia accelerated 1:21:15 - What topics will be discussed next? Impressions of the SPIEF, interest rates, and the ruble exchange rate. 1:27:05 - Conclusion